Nosocomial outbreak of ampicillin resistant Enterococcus faecium: Risk factors for infection and fatal outcome

Journal of Hospital Infection

Volumn 45, Issue 2, 2000, Pages 135-144

  Harthug, S ^a   Eide, G E ^a   Langeland, N ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ampicillin resistance; Cephalosporins; Disease outbreaks; Enterococcus faecium

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; EPIDEMIOLOGICAL DATA; FATALITY; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; NORWAY; PENICILLIN RESISTANCE; RISK FACTOR;

EID: 0033947136     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2000.0728     Document Type: Article

References (42)

1. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 4:1998;239-249.
2. George RC, Uttley AH. Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s. Epidemiol Infect. 103:1989;403-413.
3. Bingen EH, Denamur E, Zechovsky NY, Elion J. Evidence for the genetic unrelatedness of nosocomical vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol. 29:1991;1888-1892.
4. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 20:1995;96-301.
5. Patterson JE, Sweeney AH, Simms M. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine Baltimore. 74:1995;191-200.
6. Morrison AJ, Wenzel RP. Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital. Arch Intern Med. 146:1986;1549-1551.
7. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine Baltimore. 67:1998;248-269.
8. Svarva PL. Vancomycin resistant enterococci at Trondheim University Hospital. MSIS-report. 23:1995;49.
9. Kjerulf A, Pallesen L, Westh H. Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS. 104:1996;475-479.
10. Langeland N, Harthug S, Digranes A. Multidrug resistant enterococci. MSIS-report. 24:1996;13.
11. Melhus A, Tjernberg I. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis. 28:1996;191-193.
12. Hanberger H, Hoffmann M, Lindgren S, Nilsson LE. High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden. Scand J Infect Dis. 29:1997;614.
13. Torfoss D, Aukrust P, Brinch L. Carrier rate of resistant enterococci in a tertiary care hospital in Norway. Apmis. 107:1999;545-549.
14. Harthug S, Digranes A, Hope O, Kristiansen B, Allum A, Langeland N. Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium. Clin Microbial Infect. 6:2000;19-28.
15. Haarr E, Simonsen GS, Olsvik O, Sundsfjord A, Harbo K, Natas OB. First infection with vancomycin resistant type VanA enterococci in a Norwegianhospital. Tidsskr Nor Lagegeforen. 118:1998;1188-1190.
16. Harthug S, Laneland N, Digranes A. Infections caused by multiresistant enterococci in Norway. Tidsskr Nor Laegeforen. 118:1998;4070-4073.
17. Simonsen GS, Andersen BM, Digranes A. Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. Scand J Infect Dis. 30:1998;465-468.
18. Harthug S, Langeland N. Outbreak of multiresistant enterococcus faecium - risk factors for infection. APMIS. 108:2000;296-302.
19. Mohn S, Harthug S, Langeland N. Outbreak of multiresistant Enterococcus faecium in a Norwegian university hospital - risk factors for faecal colonization. J Hosp Infect. 40:1998;P3.2.18.
20. Chirurgi VA, Oster SE, Goldberg AA, McCabe RE. Nosocomial acquisition of beta-lactamase-negative, ampicillin-resistant enterococcus. Arch Intern Med. 152:1992;1457-1461.
21. Sexton DJ, Harrell LJ, Thorpe JJ, Hunt DL, Reller LB. A case-control study of nosocomial ampicillin-resistant enterococcal infection and colonization at a university hospital. Infect Control Hosp Epidemiol. 14:1993;629-635.
22. Venditti M, Fimiani C, Baiocchi P. Infections by ampicillin-resistant enterococci: a case-control study. J Chemother. 6:1994;121-126.
23. Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis. 25:1997;S206-S210.
24. Murray BE. Diversity among multidrug-resistant enterococci. Emerg Infect Dis. 4:1998;37-47.
25. Faclam RR, Washington JA II, Barlows A, Hausler WJ Jr, Herrmann KL, Isenberg HD. Streptococcusand related catalase-negative Gram-positive cocci. Manual of Clinical Microbiology. 1991;238-257.
26. Ericsson HM, Sherris JC. Antibiotic sensitivitytesting. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol. 217:1971;1.
27. Bergan T, Bruun JN, Digranes A, Lingaas E, Melby K, Sander J. Susceptibility testing of bacteria and fungi. Report from 'The Norwegian Working Group on Antibiotics'. Scand J Infect Dis. 103:1997;1-36.
28. Donabedian SM, Chow JW, Boyce JM. Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas. J Clin Microbiol. 30:1992;2757-2761.
29. Tenover FC, Arbeit RD, Goering RV. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 33:1995;2233-2239.
30. Malen S Dutka, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 33:1995;24-27.
31. McCabe W, Jackson G. Gram-negative bacteremia. II. Clinical, laboratory and therapeutic observations. Arch Intern Med. 110:1962;856-864.
32. Freid MA, Vosti KL. The importance of underlying disease in patients with gram-negative bacteremia. Arch Intern Med. 121:1968;418-423.
33. Svanbom M. A prospective study on septicemia. II. Clinical manifestations and complications, results of antimicrobial treatment and report of a follow-up study. Scand J Infect Dis. 12:1980;189-206.
34. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 16:1988;128-140.
35. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 13:1992;606-608.
36. Breslow N, Day N. Statistical Methods in Cancer Research, volume 1 - The Analysis of Case-control Studies. 1980.
37. Dixon J. BMDP Statistical Software Manual. 1992.
38. Vuopia-Varkila J, Suppola J, Klinger N, Tarkka E, Kolho E. Increase of the number of vancomycin resistant enterococci (VRE) isolated in Helsinki, Finland. Euro surveillance Monthly. 2:1997.
39. Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis. 153:1986;1075-1083.
40. Boyce JM, Opal SM, Potter G Bynoe. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother. 36:1992;1032-1039.
41. Bonten MJM, Slaughter S, Ambergen AW. The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci. Arch Intern Med. 158:1998;1127-1132.
42. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 40:1998;1-15.